Science News: Two Critiques of Psychiatry's Medical Model
Release Date: 08/04/2021
Mad in America: Science News
In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findings. This month, Peter Simons covers in detail a new systematic review that debunks the widely popularized myth of low serotonin in depression, the “chemical imbalance theory.” He then follows up with a study that found less than 25% of people respond to depression treatment in real life, and a study that found that screening for depression in...
info_outlineMad in America: Science News
In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findings. Articles covered in this podcast include: How the is of ; How ; How pharma company on its Alzheimer’s research and outcome data; How ; Researchers document how ; A study finding that ; A study on if taken during pregnancy; A paper explaining ; A paper on the ; A study finding that ; and A paper by Joanna Moncrieff on the ties between .
info_outlineMad in America: Science News
In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findings. Articles covered in this podcast include: Researchers write that ; Researchers suggest that than reliable science; Psychiatrists of any medical specialty; A promotes non-coercive mental health treatment; Black patients in the US were to be described negatively in electronic health records; A peer-supported Open Dialogue program shows ;...
info_outlineMad in America: Science News
Peter Simons covers a study in Nature finding that the positive results of psychiatry’s brain imaging studies are false; a study demonstrating that more than half of negative antidepressant trials remain unpublished or are misleadingly “spun” as positive; an article that may explain why some people don’t find meditation to be helpful; and more!
info_outlineMad in America: Science News
Peter Simons covers a study that found both therapy and medication to have very limited effectiveness; an article suggesting that general practitioners need to prescribe fewer antidepressants; a study that concluded no brain imaging test has been able to identify a meaningful brain difference in depression; and more!
info_outlineMad in America: Science News
Peter Simons covers a clinical trial that found lithium ineffective at preventing suicide attempts, an essay by Allen Frances on the overdiagnosis of depression and overprescription of antidepressants, a review of the ineffectiveness and dangers of antidepressants, and an analysis that revealed that esketamine failed five of its six clinical trials.
info_outlineMad in America: Science News
Peter Simons covers articles about the validity of psychiatric diagnoses, the medicalization of normal human experiences like grief, and how the pharmaceutical industry co-opts feminist messaging to gain approval for ineffective drugs.
info_outlineMad in America: Science News
This week, Peter Simons covers a study about the controversial practice of placebo run-in periods in antidepressant studies, a study about withdrawal symptoms being mistaken for relapse, and a book chapter that addresses stigma and discrimination.
info_outlineMad in America: Science News
This week, Peter Simons covers studies examining whether mental health literacy and essentialist thinking are associated with stigma against those with mental health problems. He also covers a study finding that psychotherapy is ineffective for the majority of children with depression.
info_outlineMad in America: Science News
This week, Peter Simons covers a study that found prolactin-increasing antipsychotics associated with increased breast cancer risk, an analysis that found no convincing evidence that screening for depression improves outcomes, and the continuing controversy around the FDA's approval of Biogen's failed Alzheimer's drug aducanumab.
info_outline